Research Paper Volume 16, Issue 6 pp 5676—5702
Identification and validation of a novel signature based on macrophage marker genes for predicting prognosis and drug response in kidney renal clear cell carcinoma by integrated analysis of single cell and bulk RNA sequencing
Figure 3. Validation of the prognostic model. (A–D) Distribution of risk scores for MMGs in TCGA-training, TCGA-test, TCGA-total and GEO cohorts, respective. (E–H) Scatter plot of the OS for each patient in the TCGA-training, TCGA-test, TCGA-total, and GEO cohorts, respectively. (I–L) Heatmaps of the risk cohort and the five MMGs in TCGA-training, TCGA-test, TCGA-total, and GEO cohorts, respectively. (M–P) The Kaplan-Meier curves in TCGA-training, TCGA-test, TCGA-total, and GEO cohorts, respectively. (Q–T) The AUC at 1-, 3-, and 5-year for the prognostic models in TCGA-training, TCGA-test, TCGA-total, and GEO cohorts, respectively.